Michael Freemark
Division of Pediatric Endocrinology and Diabetes
Duke University Medical Center
Durham
North Carolina 27710
USA
Name/email consistency: high
- Liver dysfunction in paediatric obesity: a randomized, controlled trial of metformin. Freemark, M. Acta Paediatr. (2007)
- Pharmacotherapy of childhood obesity: an evidence-based, conceptual approach. Freemark, M. Diabetes. Care (2007)
- Regulation of maternal metabolism by pituitary and placental hormones: roles in fetal development and metabolic programming. Freemark, M. Horm. Res. (2006)
- Anti-obesity medication use in adolescents: risks and benefits. Freemark, M., Kiess, W. Pediatr. Endocrinol. Rev (2004)
- Pharmacologic approaches to the prevention of type 2 diabetes in high risk pediatric patients. Freemark, M. J. Clin. Endocrinol. Metab. (2003)
- Screening for celiac disease in children with type 1 diabetes: two views of the controversy. Freemark, M., Levitsky, L.L. Diabetes. Care (2003)
- Targeted deletion of the PRL receptor: effects on islet development, insulin production, and glucose tolerance. Freemark, M., Avril, I., Fleenor, D., Driscoll, P., Petro, A., Opara, E., Kendall, W., Oden, J., Bridges, S., Binart, N., Breant, B., Kelly, P.A. Endocrinology (2002)
- Body weight and fat deposition in prolactin receptor-deficient mice. Freemark, M., Fleenor, D., Driscoll, P., Binart, N., Kelly, P. Endocrinology (2001)
- The effects of metformin on body mass index and glucose tolerance in obese adolescents with fasting hyperinsulinemia and a family history of type 2 diabetes. Freemark, M., Bursey, D. Pediatrics (2001)
- Ontogenesis of prolactin receptors in the human fetus: roles in fetal development. Freemark, M. Biochem. Soc. Trans. (2001)
- Ontogenesis of prolactin receptors in the human fetus in early gestation. Implications for tissue differentiation and development. Freemark, M., Driscoll, P., Maaskant, R., Petryk, A., Kelly, P.A. J. Clin. Invest. (1997)









